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Abstract: An efficient iridum-catalyzed asymmetric hydrogenation of 
substituted benzothiophene 1,1-dioxides is described. The use of 
iridium complexes with chiral pyridyl phosphinite ligands provides 
access to highly enantiomerically enriched sulfones with substituents 
at the 2- and 3-position. Sulfones of this type are of interest as core 
structures of agrochemicals and pharmaceuticals. Moreover, they 
can be further reduced to access chiral 2,3-dihydrobenzothiophenes. 
The asymmetric hydrogenation of heteroaromatic compounds is 
an attractive straightforward method for the synthesis of chiral 
heterocyclic compounds starting from readily available 
precursors that has recently received much attention.[1] Despite 
substantial progress in this area, efficient enantioselective 
catalysts for heteroarmatic substrates are still scarce. 
During the last decade, several highly enantioselective 
hydrogenation methods for indoles[1,2] and benzofuranes[1,3] have 
been reported. However, related benzothiophenes have been 
rarely investigated as substrates. Only recently, the group of 
Glorius has reported an efficient chiral Ru-catalyst[4] for the 
enantioselective reduction of thiophenes and benzothiophenes[5] 
among other heteroaromatic compounds[1f] (Scheme 1). 
Although this work marks a breakthrough, the substrate scope is 
rather limited, especially in the case of benzothiophenes, as only 
primary alkyl substituents at either the 2- or the 3-position are 
tolerated. 
Scheme 1. Enantioselective reduction of benzothiophenes and proposed 
asymmetric hydrogenation of benzothiophene 1,1-dioxides. 
Subsequent to our studies of Ir N,P complexes as catalysts 
for the asymmetric hydrogenation of furans and benzofurans,[3b] 
we investigated benzothiophenes as substrates but without 
success. Consequently, we decided to study benzothiophene 
1,1-dioxides as surrogates that could be converted to chiral 2,3-
dihydrobenzothiophenes by reduction of the sulfone group. We 
reasoned that the reduced aromatic character and the absence 
of sulfur lone pairs, which could inhibit the catalyst by 
coordination, would facilitate hydrogenation. Moreover, 
Andersson et al. had demonstrated that unsaturated sulfones 
are suitable substrates for Ir-catalyzed asymmetric 
hydrogenation.[6] In addition, chiral 2,3-dihydrobenzothiophene 
1,1-dioxides have found interest in agro and medicinal chemistry 
as herbicides, insecticides,[7] and inhibitors of the hypoxia-
inducible factor HIF2α.[8]  
For initial studies we chose 2-phenylbenzothiophene 1,1-
dioxide 1a as test substrate for the screening of a series of Ir 
catalysts developed in our group (Table 1).[9] Under a H2 
atmosphere of 50 bar, most catalysts gave only moderate to low 
conversion with the exception of Ir complexes based on ligands 
L5, L12 and L14 (entries 5, 12 and 14). N,P-ligands with alkyl-
substituted phosphine or phosphinite units showed higher 
activity than their aryl-substituted analogues (cf. entries 1, 3, 5 
and 13 vs. 2, 4, 6 and 14 respectively). Pleasingly, the most 
active catalyst [Ir(COD)L5]BArF also induced the highest 
enantioselectivity, affording 2a in 97% ee (entry 5). 
With a promising catalyst in hand, we briefly tested six 
analogues of ligand L5 with different substituents on the 
phosphorus atom (Cy, t-Bu) and the pyridine ring (H, Me, Ph). 
Both the presence of a di-tert-butyl phosphinite unit and a phenyl 
group on the pyridine ring proved to be essential to achieve high 
conversion and enantioselectivity (see Supporting Information). 
Lowering the hydrogen pressure from 50 to 10 bar reduced the 
conversion from 97% to 90% with no apparent effect on the 
enantioselectivity. Therefore, the original conditions specified in 
Table 1 were chosen for further studies using a variety of 2- and 
3-arylbenzothiophene 1,1-dioxides as substrates (Table 2).
First substrate 1a was compared with para-, meta-, and
ortho-tolyl analogues. A p-Me group (substrate 1b) had only 
marginal effects on conversion (97 vs. 95%) and 
enantioselectivity (97 vs. 98% ee), whereas a m-Me group (1c) 
slowed down the reaction significantly. However, at higher 
catalyst loading (2 mol%) full conversion and 97% ee were 
achieved. The o-Me derivative 1d, on the other hand, gave only 
low conversion even with 2 mol% of catalyst, although the 
enantioselectivity remained high. Apparently the reaction is 
rather sensitive to steric hindrance in the 2-position. Both the 
para-fluoro and para-methoxy derivatives 1e and 1f reacted with 
high enantioselectivity. Compared to 1a, the electron-
withdrawing fluorophenyl group in 1e lowered the reactivity while 
the opposite effect was observed for the para-methoxyphenyl 
derivative 1f. 
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Table 1. Catalyst screening for the asymmetric hydrogenation of 
benzothiophene 1,1-dioxide 1a. 
 
Entry L Conv. 
[%][a] 




1 L1 45 32 8 L8 60 6 
2 L2 70 24 9 L9 23 38 
3 L3 29 74 10 L10 32 32 
4 L4 68 24 11 L11 66 35 
5 L5 97 97 12 L12 >99 54 
6 L6 31 83 13 L13 29 42 
7 L7 69 74 14 L14 90 91 
 
BArF = (tetrakis(3,5-bis(trifluoromethyl)phenyl)borate; COD = 1,5-
cyclooctadiene; [a] Determined by GC analysis (see the supporting 
information for details); [b] Determined by HPLC analysis. 
 
The same catalyst [Ir(COD)L5]BArF also performed well in 
the asymmetric hydrogenation of analogous 3-aryl-substituted 
substrates. Benzothiophene 1,1-dioxides 1g and 1h reacted with 
high levels of conversion and enantioselectivity comparable to 
the 2-substituted isomers 1a and 1b. However, the increased 
steric hindrance of meta- and ortho-tolyl substituents seemed to 
have a less dramatic effect for 3-aryl benzothiophene 1,1-
dioxides. In fact, compound 1i reacted smoothly in the presence 
of 1 mol% of catalyst, affording 2i with 92% conversion and 98% 
ee. Even compound 1j, bearing an o-tolyl substituent at the 3-
position, was reduced with 84% conversion and 94% ee, 
although in this case an increased catalyst loading (2 mol%) was 
necessary. Again, the electron-poor substrate 1k gave lower 
conversion than the electron-rich analogue 1l and also 
somewhat lower ee.  
To examine the reactivity of alkyl-substituted substrates, 2- 
methylbenzothiophene 1,1-dioxide 3a was hydrogenated under 
standard conditions used for substrates 1a-l (Table 3). Although  
Table 2. Investigation of the substrate scope. 
 
Reactions run on a 33 μmol scale. Conversions determined by GC analysis. 
Ees determined by HPLC analysis. [a] (S) absolute configuration determined 
by single crystal X-ray analysis;[10] [b] 2 mol% of [Ir(COD)L5]BArF were used. 
high conversion to 4a (97%) was achieved, the level of 
enantioselectivity induced by the catalyst based on ligand L5 
was disappointing (entry 5). Consequently, screening of several 
other iridium complexes was carried out to identify a more 
selective catalyst for alkyl-substituted substrates (Table 3). 
Whilst most catalysts reduced 3a with poor conversion and 
enantioselectivity, [Ir(COD)L14]BArF displayed high reactivity 
affording product 4a with 99% conversion but poor 
enantioselectivity (entry 14). Surprisingly, the Ir-complex based 
on ligand L4, differing from L5 only in the size of the carbocycle 
condensed to the pyridine ring, turned out to be the most active 
and selective catalyst, giving full conversion and 92% ee (entry 
4). Further optimization of the reaction conditions (see the 
Supporting Information) revealed that for substrate 3a full 
conversion and slightly higher stereoselectivity (93% ee) could 
be achieved in only 1 h at 2 bar H2 pressure. In addition, 
variation of the substituents on ligand L4 showed that both tert-
butyl groups on the phosphorus atom and a phenyl group 
flanking the pyridine nitrogen atom are essential to get good 
results, paralleling the observations made earlier with L5 (see 











































































Table 3. Catalyst screening for the asymmetric hydrogenation of 










1 L1 9 13 8 L8 14 4 
2 L2 20 28 9 L9 10 20 
3 L3 25 17 10 L10 16 46 
4 L4 >99[c] 93 (S)[d] 11 L11 25 2 
5 L5 97 5 12 L12 58 3 
6 L6 9 36 13 L13 9 37 
7 L7 3 11 14 L14 99 42 
[a] Determined by GC analysis; [b] Determined by HPLC analysis; [c] Reaction 
also scaled up to 0.55 mmol scale (isolated yield 99%); [d] (S) absolute 
configuration according to the optical rotation of 5a (see Scheme 2). 
The results of further studies with a series of 2- and 3-alkyl-
substituted benzothiophene 1,1-dioxides using [Ir(COD)L4]BArF 
as catalyst are shown in Table 4. Replacement of the methyl 
substituent in substrate 3a by an ethyl group led to a decrease 
of reactivity and ee. Longer reaction times were necessary to 
reduce 3b with 95% conversion, affording product 4b with 84% 
ee. Lower temperatures resulted in drastically lower reactivity 
without affecting the enantioselectivity (see the Supporting 
Information). An n-propyl or benzyl group at the 2-position 
further reduced the enantioselectivity. For the benzyl-substituted 
substrate 3d more forcing conditions had to be used (10 bar H2 
for 8 h) to attain 4d in >90% conversion. The more sterically 
hindered 2-isopropyl derivative 3e showed even lower reactivity 
and gave only 50% ee. Higher enantioselectivity was achieved 
with the catalyst derived from ligand L5. 
When substrate 3e was hydrogenated using 2 mol% of 
[Ir(COD)L5]BArF under 50 bar hydrogen pressure, 75% 
conversion was achieved after 24 h with an ee of 84%. Notably, 
substrate 3f, containing a protected alcohol functionality, 
displayed exceptionally high reactivity, being fully reduced within 
one hour under 2 bar of H2, however, with only moderate 
enantioselectivity. Finally, we examined the 3-methyl-substituted 
benzothiophene 1,1-dioxide 3g. Although this substrate proved 
far less reactive than the 2-methyl isomer 3a, it was fully 
converted to product 4g within 4 h under 50 bar H2 with high 
enantiomeric excess of 93% ee. 
To demonstrate the synthetic value of the hydrogenation 
products, we studied the reduction of selected chiral 2,3-
dihdrobenzothiophene 1,1-dioxides to the corresponding 2,3- 
dihydrobenzothiophenes (Scheme 2). Using an excess of LiAlH4 
in THF, reactions proceeded smoothly in high yield with 
negligible or no loss of enantiomeric purity, thus providing 
access to highly enantiomerically enriched 2- and 3-substituted 
2,3-dihydrobenzothiophenes 5a and 5g. Moreover, the acidity of 
the proton next to the SO2 group allows the introduction of an  
 
Table 4. Substrate scope of the asymmetric hydrogenation. 
 
Reactions run on a 33 μmol scale. Conversions determined by GC analysis. 
Ees determined by HPLC analysis on a chiral stationary phase (see the 
supporting information for details); [a] 2 mol% of [Ir(COD)L5]BArF were used; 
[b] Reaction also scaled up to 1.63 mmol scale (99% yield of isolated product, 
93% ee); [c] (S) absolute configuration determined by single crystal X-ray 
analysis.[10] 
additional substituent in the 2-position. As example we 
converted 3-methyl-2,3-dihydrobenzothiophene dioxide  5g to 
the trans-2,3-dimethyl derivative 6 in high yield with a dr of 81:19 
by deprotonation with nBuLi and subsequent methylation with 
dimethyl sulfate. In this way 2,3-disubstituted 
dihydrobenzothiophenes are accessible, which cannot be 
prepared by asymmetric hydrogenation because of the lack of 
reactivity of tetrasubstituted C=C bonds. 
 
 
Scheme 2. Conversion of 2,3-dihydrobenzothiophene 1,1-dioxides into 2,3-
dihydrobenzothiophenes, diastereoselective methylation of compound 4g, and 
ORTEP view of (2R,3S)-6.[10] [a] The dr was determined by GC analysis of the 




























3b, conv. 95%, 84% ee
(L4, 2 bar H2, 2 h)
3c, conv. 94%, 74% ee
(L4, 2 bar H2, 2 h)
3d, conv. 93%, 69% ee
(L4, 10 bar H2, 8 h)
3e, conv. 22%, 50% ee
(L4, 10 bar H2, 1 h)
3e, conv. 18%, 86% ee
(L5, 10 bar H2, 1 h)
3e, conv. 22%, 86% ee
(L5, 10 bar H2, 8 h)
3e, conv. 75%, 84% ee[a]
(L5, 50 bar H2, 24 h)
3f, conv. >99%, 71% ee
(L4, 2 bar H2, 1 h)
3g, conv. 84%, 93% ee
(L4, 10 bar H2, 4 h)
3g, conv. >99%, 93% ee[b,c]







































































In summary, we have identified two chiral Ir N,P-ligand 
complexes that enable the enantioselective hydrogenation of 
benzothiophene 1,1-dioxides. Excellent enantioselectivities and 
high yields were obtained for substrates bearing an aromatic 
substituent at either the 2- or the 3- position of the heterocyclic 
scaffold. Analogous alkyl-substituted derivatives proved to be 
more demanding substrates giving less consistent results (69-
93% ee; 75-100% conversion). Subsequent reduction of the 
sulfone group gives access to highly enantiomerically enriched 
dihydrothiophenes. In this way 2- and 3-aryl-dihydro-
benzothiophenes can be prepared that are not available by 
direct asymmetric hydrogenation of benzothiophenes as 
described by Glorius et al.,[5] because their method is not 
applicable to aryl substituted derivatives.   
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D. Schlüns, J. Neugebauer, R. Wolf, F. Glorius, Organometallics 2016, 
35, 3641–3646 and references therein. 
[5] S. Urban, B. Beiring, N. Ortega, D. Paul, F. Glorius, J. Am. Chem. Soc. 
2012, 134, 15241–15244. 
[6] a) T. Zhou, B. Peters, M. F. Maldonado, T. Govender, P. G. Andersson, 
J. Am. Chem. Soc. 2012, 134, 13592–13595; b) B. K. Peters, T. Zhou, 
J. Rujirawanich, A. Cadu, T. Singh, W. Rabten, S. Kerdphon, P. G. 
Andersson, J. Am. Chem. Soc. 2014, 136, 16557–16562. 
[7] a) H. Rempfler, A. Edmunds, A. De Mesmaeker, K. Seckinger (Novartis 
AG), WO 9909023, 1999; c) M. Saitou, H. Sekiguchi, S. Ogawa 
(Idemitsu Kosan Co., Ltd.), WO 2000069853, 2000; d) M. Saitou, H. 
Sekiguchi, S. Ogawa (Idemitsu Kosan Co., Ltd.), WO 2000020408, 
2000; e) R. G. Hall, O. Loiseleur, J. Pabba, S. Pal, A. Jeanguenat, A. 
Edmunds, A. Stoller (Syngenta AG), WO 2009010260, 2009; f) A. 
Edmunds; M. Mühlebach; A. Stoller; O. Loiseleur; A. Buchholz; O. F. 
Hueter; A. Bigot; R. G. Hall; D. Emery; P. J. M. Jung; L. Lu; Y. Wu; R. 
Chen (Syngenta AG), WO 2015000715, 2015. 
[8] a) D. D. Dixon, J. Grina, J. A. Josey, J. P. Rizzi, S. T. Schlachter, E. M. 
Wallace, B. Wang, P. When, R. Xu, H. Yang (Peloton Therapeutics, 
Inc.), WO 2015095048, 2015; b) P. Wehn, H. Yang (Peloton 
Therapeutics, Inc.), US 20160362390, 2016. 
[9] a) S. J. Roseblade, A. Pfaltz, Acc. Chem. Res. 2007, 40, 1402–1411; b) 
D. H. Woodmansee, A. Pfaltz, Chem. Commun. 2011, 47, 7912–7916. 
[10] CCDC-928151 (2a), CCDC-928152 (2l), CCDC-928153 (4g) and 
CCDC-928154 (6) contain the supplementary crystallographic data for 
this paper. These data can be obtained free of charge from The 





































































Entry for the Table of Contents 
COMMUNICATION 
Ir-catalyzed asymmetric hydrogenation of benzothiophene 1,1-dioxides gives 
access to highly enantiomerically enriched sulfones with substituents at the 2- and 
3-position. Sulfones of this type are of interest as core structures of agrochemicals
and pharmaceuticals. Moreover, they can be further reduced to provide chiral 2,3-
dihydrobenzothiophenes.
Paolo Tosatti, Andreas Pfaltz* 
Page No. – Page No. 
Iridium-catalyzed asymmetric 
hydrogenation of benzo[b]thiophene 
1,1-dioxides 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
